Sponsors (4)
Referred to the House Committee on Energy and Commerce.
Requires the Department of Health and Human Services, through the National Institute of Environmental Health Sciences, to fund research on how personal care products that contain endocrine‑disrupting chemicals affect the female reproductive system and to report findings to Congress every five years. Directs HHS to award grants to States for investigation programs and public awareness campaigns about safer alternative personal care products, and to report on those State activities every five years. The section also defines key terms used in the law.
The Secretary of Health and Human Services, acting through the Director of the National Institute of Environmental Health Sciences, shall award grants for research on the impact of personal care products containing endocrine-disrupting chemicals on the female reproductive system and related reproductive toxicity concerns.
Not later than 5 years after the date of enactment, and every 5 years thereafter, the Secretary shall submit to Congress and make publicly available on the appropriate Department of Health and Human Services website a report based on the results of the research required above. The report must (A) outline research developments and findings related to disparities in access to safe non-endocrine-disrupting personal care products; (B) list safe and harmful personal care products, as determined by the Secretary; and (C) include evidence-based or evidence-informed legislative or administrative strategies to increase the Food and Drug Administration’s domain to regulate personal care product ingredients that are endocrine-disrupting chemicals that harm women’s reproductive health.
The Secretary shall award grants to States for carrying out programs to investigate the impact of personal care products containing endocrine-disrupting chemicals on women’s reproductive health, and for programs to develop and implement public awareness and education campaigns about the use of alternative personal care products that are less harmful to human health.
Not later than 5 years after the initial awarding of grants to States under the State grants provision, and every 5 years thereafter, the Secretary shall submit to Congress and make publicly available on the appropriate Department of Health and Human Services website a report summarizing the findings and results of the programs and activities funded through those grants.
"Endocrine-disrupting chemical" means a chemical that mimics, blocks, or interferes with the body’s hormones.
Who is affected and how:
Women of reproductive age and pregnant people: most directly affected because the research targets effects on the female reproductive system; results could inform health guidance, clinical care, and consumer choices.
Consumers generally: increased public awareness campaigns aim to inform consumers about safer alternative personal care products and reduce exposures.
State public health agencies: will be eligible for grants to investigate product risks and to run outreach campaigns; agencies will need capacity to carry out investigations and education activities.
Federal research and public health agencies (HHS/NIEHS): will allocate staff and resources to run the research program, manage grants, and produce periodic reports to Congress.
Personal care product manufacturers and retailers: could be indirectly affected if research and outreach change consumer demand, influence voluntary reformulation, or lead to future regulatory or market changes.
Public health and environmental health researchers: will gain dedicated federal funding opportunities to study endocrine disruptors in consumer products and to publish evidence that may guide policy and clinical practice.
Potential benefits:
Potential costs and limits:
Equity considerations:
Last progress June 5, 2025 (8 months ago)
Introduced on June 5, 2025 by Shontel M. Brown